AWHONN Perinatal Orientation And Education Program (POEP) Practice Exam

The key aspect of antiretroviral treatment for HIV in pregnancy is that it is essential for reducing perinatal transmission risk. Research has shown that when pregnant individuals with HIV receive antiretroviral therapy, the viral load can be significantly reduced, substantially lowering the chance of transmitting the virus to the baby during pregnancy, labor, or breastfeeding. The effectiveness of antiretroviral treatment begins early in pregnancy and continues to have protective benefits as the pregnancy progresses. Starting the treatment as early as possible is critical in ensuring not only the health of the mother but also the well-being of the fetus. The overall goal is to maintain an undetectable viral load throughout pregnancy to promote the best outcomes for both the parent and child. In contrast, the other options do not reflect the current understanding and recommendations surrounding HIV treatment in pregnancy. For example, antiretroviral treatment is not optional; it is strongly advised for those living with HIV to minimize transmission risks. Additionally, starting treatment only after delivery or considering its effectiveness limited to the third trimester does not align with established medical guidelines, which emphasize the importance of ongoing treatment throughout the entire pregnancy.